Nabil Gharios

Nabil founded DNA Finance in 2015.

He began his career in mergers and acquisitions in the healthcare sector at Cowen in New York.

Between 2001 and 2005, he worked as an associate at Bioam, a healthcare-focused venture capital fund based in Paris.

From 2005 to 2011, he held several senior positions at Abbott Laboratories, including European Business Development Team Manager, International Brand Manager for the anesthesia franchise, generating approximately €600 million in revenue, as well as Special Projects Manager at the European headquarters.

Nabil founded Biotech Promise, an investment fund dedicated to listed healthtech companies, and was also responsible for the health sector within the French Society of Financial Analysts (SFAF).

Nabil is a graduate of École Centrale de Paris, one of the leading engineering schools in France.